Background & aims: Pathological esophageal acid exposure may persist in patients with Barrett's esophagus (BE), despite proton pump inhibitor (PPI) administration and symptom control. We aimed to determine the role of esophageal function testing in assessing acid exposure in patients with BE on PPI therapy and predicting disease progression.
Esophageal Function Testing Identifies Barrett's Esophagus Patients With Pathological Acid Exposure at Risk for Neoplasia
Savarino Edoardo
2025
Abstract
Background & aims: Pathological esophageal acid exposure may persist in patients with Barrett's esophagus (BE), despite proton pump inhibitor (PPI) administration and symptom control. We aimed to determine the role of esophageal function testing in assessing acid exposure in patients with BE on PPI therapy and predicting disease progression.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
